These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 29783441)

  • 21. Personalized medicine and the role of health economics and outcomes research: issues, applications, emerging trends, and future research.
    O'Donnell JC
    Value Health; 2013; 16(6 Suppl):S1-3. PubMed ID: 24034305
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The faces of personalized medicine: a framework for understanding its meaning and scope.
    Redekop WK; Mladsi D
    Value Health; 2013; 16(6 Suppl):S4-9. PubMed ID: 24034312
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human genome project: pharmacogenomics and drug development.
    Ganguly NK; Bano R; Seth SD
    Indian J Exp Biol; 2001 Oct; 39(10):955-61. PubMed ID: 11883519
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical practice on the horizon: personalized medicine.
    Chadwell K
    Clin Nurse Spec; 2013; 27(1):36-43. PubMed ID: 23222027
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ethical and legal aspects of oncogenomics.
    Stankov K; Draskovic D; Mikov M
    J BUON; 2012; 17(2):383-8. PubMed ID: 22740222
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A road toward better education in personalized medicine at universities and beyond.
    Karlikova M; Polivka J; Strojil J; Topolcan O
    Per Med; 2015 Jun; 12(3):259-267. PubMed ID: 29771646
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Working towards personalization in medicine: main obstacles to reaching this vision from today's perspective.
    Leyens L; Horgan D; Lal JA; Steinhausen K; Satyamoorthy K; Brand A
    Per Med; 2014 Sep; 11(7):641-649. PubMed ID: 29764055
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The current status and future potential of personalized diagnostics: Streamlining a customized process.
    Richmond TD
    Biotechnol Annu Rev; 2008; 14():411-22. PubMed ID: 18606372
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Academia at the crossroads: education and training in pharmacogenomics.
    Lesko LJ; Johnson JA
    Per Med; 2012 Jul; 9(5):497-506. PubMed ID: 29768769
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Ethical and social issues associated with genomic medicine].
    Barazzetti G; Kaufmann A; Benaroyo L
    Praxis (Bern 1994); 2014 May; 103(10):573-7. PubMed ID: 24800769
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Key Lessons Learned from Moffitt's Molecular Tumor Board: The Clinical Genomics Action Committee Experience.
    Knepper TC; Bell GC; Hicks JK; Padron E; Teer JK; Vo TT; Gillis NK; Mason NT; McLeod HL; Walko CM
    Oncologist; 2017 Feb; 22(2):144-151. PubMed ID: 28179575
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Integrating genomics and neuromarkers for the era of brain-related personalized medicine.
    Gordon E
    Per Med; 2007 May; 4(2):201-215. PubMed ID: 29788634
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Benefit-risk management in the age of personalized healthcare.
    Forstner M
    Per Med; 2012 Jul; 9(5):507-514. PubMed ID: 29768767
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 4th Annual Pharmacogenomics and Medicine Lectures.
    Oestreicher P
    Pharmacogenomics; 2001 Aug; 2(3):291-6. PubMed ID: 11939134
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular profiling and companion diagnostics: where is personalized medicine in cancer heading?
    Verma M
    Per Med; 2014 Nov; 11(8):761-771. PubMed ID: 29764045
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Translational strategies to implement personalized medicine: rheumatoid arthritis examples.
    Littman BH
    Per Med; 2009 Jul; 6(4):429-437. PubMed ID: 29783543
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ethical, legal, and social issues in the translation of genomics into health care.
    Badzek L; Henaghan M; Turner M; Monsen R
    J Nurs Scholarsh; 2013 Mar; 45(1):15-24. PubMed ID: 23369261
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Current developments in genomics and personalized health care: impact on public health.
    Manamperi A
    Asia Pac J Public Health; 2008; 20(3):242-50. PubMed ID: 19124318
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ethical, legal and social implications of incorporating personalized medicine into healthcare.
    Brothers KB; Rothstein MA
    Per Med; 2015; 12(1):43-51. PubMed ID: 25601880
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Milestones in Personalized Medicine: From the Ancient Time to Nowadays-the Provocation of COVID-19.
    Visvikis-Siest S; Theodoridou D; Kontoe MS; Kumar S; Marschler M
    Front Genet; 2020; 11():569175. PubMed ID: 33424917
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.